Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,396 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design.
McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller TJ, Woods SW, Hawkins KA, Hoffman R, Lindborg S, Tohen M, Breier A. McGlashan TH, et al. Among authors: perkins d. Schizophr Res. 2003 May 1;61(1):7-18. doi: 10.1016/s0920-9964(02)00439-5. Schizophr Res. 2003. PMID: 12648731 Clinical Trial.
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample.
Miller TJ, Zipursky RB, Perkins D, Addington J, Woods SW, Hawkins KA, Hoffman R, Preda A, Epstein I, Addington D, Lindborg S, Marquez E, Tohen M, Breier A, McGlashan TH. Miller TJ, et al. Among authors: perkins d. Schizophr Res. 2003 May 1;61(1):19-30. doi: 10.1016/s0920-9964(02)00440-1. Schizophr Res. 2003. PMID: 12648732 Clinical Trial.
Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.
Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, McFarlane W, Perkins DO, Pearlson GD, Woods SW. Miller TJ, et al. Among authors: perkins do. Schizophr Bull. 2003;29(4):703-15. doi: 10.1093/oxfordjournals.schbul.a007040. Schizophr Bull. 2003. PMID: 14989408
North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research.
Addington J, Cadenhead KS, Cannon TD, Cornblatt B, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Heinssen R; North American Prodrome Longitudinal Study. Addington J, et al. Among authors: perkins do. Schizophr Bull. 2007 May;33(3):665-72. doi: 10.1093/schbul/sbl075. Epub 2007 Jan 25. Schizophr Bull. 2007. PMID: 17255119 Free PMC article.
Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.
Seidman LJ, Giuliano AJ, Meyer EC, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Bearden CE, Christensen BK, Hawkins K, Heaton R, Keefe RS, Heinssen R, Cornblatt BA; North American Prodrome Longitudinal Study (NAPLS) Group. Seidman LJ, et al. Among authors: perkins do. Arch Gen Psychiatry. 2010 Jun;67(6):578-88. doi: 10.1001/archgenpsychiatry.2010.66. Arch Gen Psychiatry. 2010. PMID: 20530007 Free PMC article.
Altered age-related trajectories of amygdala-prefrontal circuitry in adolescents at clinical high risk for psychosis: a preliminary study.
Gee DG, Karlsgodt KH, van Erp TG, Bearden CE, Lieberman MD, Belger A, Perkins DO, Olvet DM, Cornblatt BA, Constable T, Woods SW, Addington J, Cadenhead KS, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Cannon TD; NAPLS Consortium. Gee DG, et al. Among authors: perkins do. Schizophr Res. 2012 Jan;134(1):1-9. doi: 10.1016/j.schres.2011.10.005. Epub 2011 Nov 6. Schizophr Res. 2012. PMID: 22056201 Free PMC article.
Sex- and Age-Specific Deviations in Cerebellar Structure and Their Link With Symptom Dimensions and Clinical Outcome in Individuals at Clinical High Risk for Psychosis.
Sefik E, Boamah M, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan MS, Mathalon DH, Perkins DO, Stone WS, Tsuang MT, Woods SW, Cannon TD, Walker EF. Sefik E, et al. Among authors: perkins do. Schizophr Bull. 2023 Mar 15;49(2):350-363. doi: 10.1093/schbul/sbac169. Schizophr Bull. 2023. PMID: 36394426 Free PMC article.
Accelerated cortical thinning precedes and predicts conversion to psychosis: The NAPLS3 longitudinal study of youth at clinical high-risk.
Collins MA, Ji JL, Chung Y, Lympus CA, Afriyie-Agyemang Y, Addington JM, Goodyear BG, Bearden CE, Cadenhead KS, Mirzakhanian H, Tsuang MT, Cornblatt BA, Carrión RE, Keshavan M, Stone WS, Mathalon DH, Perkins DO, Walker EF, Woods SW, Powers AR, Anticevic A, Cannon TD. Collins MA, et al. Among authors: perkins do. Mol Psychiatry. 2023 Mar;28(3):1182-1189. doi: 10.1038/s41380-022-01870-7. Epub 2022 Nov 25. Mol Psychiatry. 2023. PMID: 36434057 Free PMC article.
Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS.
Woods SW, Parker S, Kerr MJ, Walsh BC, Wijtenburg SA, Prunier N, Nunez AR, Buccilli K, Mourgues-Codern C, Brummitt K, Kinney KS, Trankler C, Szacilo J, Colton BL, Ali M, Haidar A, Billah T, Huynh K, Ahmed U, Adery LL, Corcoran CM, Perkins DO, Schiffman J, Perez J, Mamah D, Ellman LM, Powers AR 3rd, Coleman MJ, Anticevic A, Fusar-Poli P, Kane JM, Kahn RS, McGorry PD, Bearden CE, Shenton ME, Nelson B, Calkins ME, Hendricks L, Bouix S, Addington J, McGlashan TH, Yung AR; Accelerating Medicines Partnership Schizophrenia. Woods SW, et al. Among authors: perkins do. medRxiv [Preprint]. 2023 May 2:2023.04.29.23289226. doi: 10.1101/2023.04.29.23289226. medRxiv. 2023. Update in: Early Interv Psychiatry. 2024 Apr;18(4):255-272. doi: 10.1111/eip.13457 PMID: 37205422 Free PMC article. Updated. Preprint.
1,396 results